# EDGAR Filing Document

**Accession Number:** 0001848416
**File Stem:** 0001493152-23-005269
**Filing Date:** 2023-2
**Character Count:** 10992
**Document Hash:** b5cccb7087a45b82f141f9f8171cae5b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-23-005269.hdr.sgml**: 20230216

**ACCESSION NUMBER**: 0001493152-23-005269

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20230216

**ITEM INFORMATION**: Other Events

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230216

**DATE AS OF CHANGE**: 20230216

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Verano Holdings Corp.
- **CENTRAL INDEX KEY:** 0001848416
- **STANDARD INDUSTRIAL CLASSIFICATION:** AGRICULTURE PRODUCTION - CROPS [0100]
- **IRS NUMBER:** 981583243
- **STATE OF INCORPORATION:** A1
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-56342
- **FILM NUMBER:** 23637132

**BUSINESS ADDRESS:**
- **STREET 1:** 415 NORTH DEARBORN STREET
- **STREET 2:** 4TH FLOOR
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60654
- **BUSINESS PHONE:** 312-265-0730

**MAIL ADDRESS:**
- **STREET 1:** 415 NORTH DEARBORN STREET
- **STREET 2:** 4TH FLOOR
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60654

?xml version="1.0" encoding="utf-8"?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

 **Pursuant to Section 13 or 15(d)**

**of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported): February 16, 2023**

**VERANO HOLDINGS CORP.**

**(Exact Name of Registrant as Specified in its Charter)** 

------

---

| | | |
|:---|:---|:---|
| **British Columbia** | **000-56342** | **98-1583243** |
| **(State or Other Jurisdiction of Incorporation)** | **(Commission**<br> **File Number)**<br>| **(IRS Employer**<br> **Identification No.)** |

---

---

| | |
|:---|:---|
| **415 North Dearborn Street** **, 4<sup>th</sup> Floor,** |  |
| **Chicago, Illinois** | **60654** |
| **(Address of Principal Executive Offices)** | **(Zip Code)** |

---

**(312) 265-0730**

**(Registrant's Telephone Number, Including Area Code)**

**N/A**

**(Former Name or Former Address, if Changed Since Last Report)**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol** | **Name of each exchange on which registered** |
| **N/A** | **N/A** | **N/A** |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

**Item 8.01** **Other Events.**

On February 16, 2023, Verano Holdings Corp. (the "Company") issued a press release announcing the grand opening of Zen Leaf Clifton Heights on Friday, February 17, 2023, bringing the Company's total dispensary count to 16 in Pennsylvania and 123 nationwide. A copy of such press release is filed as Exhibit 99.1 to this report.

The information furnished under this item 8.01, including Exhibit 99.1 incorporated by reference herein, shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section and shall not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act.

**Item 9.01 Financial Statements and Exhibits.**

(d) Exhibits

<u>Exhibit No.</u> <u>Description</u> <br> 99.1 [Press Release issued on February 16, 2023](ex99-1.htm) <br> 104 Cover Page Interactive Data File (embedded within the Inline XBRL)

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | VERANO HOLDINGS CORP. | VERANO HOLDINGS CORP. |
| Date: February 16, 2023 | By: | */s/ Darren Weiss* |
|  | Name: | Darren Weiss |
|  | Title: | Chief Operating Officer, Chief Legal Officer, General Counsel & Secretary |

---

## Exhibit 99.1

**Exhibit 99.1**

![](ex99-1_001.jpg)

**Verano Announces the Opening of Zen Leaf Clifton Heights, the Company's 16<sup>th</sup> Affiliated Pennsylvania Dispensary and 123<sup>rd</sup> Location Nationwide**

● Zen
 Leaf Clifton Heights is the Company's 16<sup>th</sup> affiliated Pennsylvania dispensary and seventh retail location in the
 greater Philadelphia area, joining existing local outlets in Abington, Chester, Malvern, Philadelphia, West Chester and Wynnewood

● Zen
 Leaf is the first medical cannabis dispensary in Clifton Heights, a town with a population of over 6,700<sup>1</sup>

● Verano's
 active operations span 13 states, comprised of 123 dispensaries and 14 cultivation and processing facilities with more than 1 million
 square feet of cultivation capacity

CHICAGO, February 16, 2023 – Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) ("Verano" or the "Company"), a leading multi-state cannabis company, today announced the grand opening of its 16<sup>th</sup> affiliated Pennsylvania dispensary, Zen Leaf Clifton Heights, on Friday, February 17 at 9 a.m. local time, following a ceremonial ribbon cutting at 8:45 a.m. Zen Leaf Clifton Heights, located at 5321 West Baltimore Pike, is open Monday through Saturday from 9 a.m. to 8 p.m. and Sunday from 10 a.m. to 6 p.m. local time.

Zen Leaf Clifton Heights is located in the greater Philadelphia area in Delaware County near the border of Philadelphia County, the most densely populated county in the Commonwealth. Zen Leaf Clifton Heights adds another convenient location for patients in northeast Philadelphia that complements the Company's existing affiliated Zen Leaf dispensaries in Abington, Chester, Malvern, Philadelphia, West Chester and Wynnewood.

"We're thrilled to welcome Pennsylvania medical cannabis patients to Zen Leaf Clifton Heights, where we're proud to offer convenient access to our expansive suite of high-quality cannabis products and a superior shopping experience guided by our compassionate team members," said George Archos, Verano Founder and Chief Executive Officer. "I'm grateful for the support of our employees, our valued patients and the community as we welcome patients at our newest Zen Leaf location and further expand our footprint in the important Pennsylvania market."

Zen Leaf Clifton Heights will offer a suite of cannabis therapeutics, including the Company's signature Verano Reserve and Essence flower, concentrates and vapes, Savvy flower and extracts, and Avexia RSO cannabis oil. For additional convenience and accessibility, patients can choose to order ahead at <u>ZenLeafDispensaries.com</u> for express in-store or curbside pickup.

For more information about Zen Leaf medical cannabis dispensaries, visit <u>ZenLeafDispensaries.com</u>.

<sub>1 <u>United States Census Bureau</u> </sub>

**About Verano**

Verano is a leading, vertically integrated, multi-state cannabis operator in the U.S., devoted to the ongoing improvement of communal wellness by providing responsible access to regulated cannabis products. With a mission to address vital health and wellness needs, Verano produces a comprehensive suite of premium, innovative cannabis products sold under its trusted portfolio of consumer brands, including Verano™, Avexia™, BITS™, Encore™, MÜV™ and Savvy™. Verano's portfolio encompasses 14 U.S. states, with active operations in 13, including 14 production facilities comprising over 1,000,000 square feet of cultivation capacity. Verano designs, builds, and operates dispensaries under retail brands including Zen Leaf™ and MÜV™, delivering a superior cannabis shopping experience in both medical and adult use markets. Learn more at www.verano.com.

**Contacts:**

**Media**

Verano

Grace Bondy

Senior Manager, Communications

<u>Grace.Bondy@verano.com</u>

**Investors**

Verano

Julianna Paterra, CFA

Vice President, Investor Relations

<u>Julianna.Paterra@verano.com</u>

**Forward Looking Statements**

This press release may contain "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company's control. Generally, such forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "future", "scheduled", "estimates", "forecasts", "projects" "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved". Forward-looking statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking statements herein, including, without limitation, the risk factors described in the Company's registration statement on Form 10, as amended, and quarterly reports on Form 10-Q filed with the U.S. Securities and Exchange Commission at www.sec.gov. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information or forward-looking statements that are contained or referenced herein, except as may be required in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice regarding forward-looking information and statements.

###